Alcohol use disorder: clinical biology and epidemiology

The seminar highlights the utility of phosphatidylethanol (PEth) as a reliable biomarker for assessing alcohol use. Contributions discussed the role of pharmacological treatments for Alcohol Use Disorder (AUD), showcasing various drug options available for managing the condition. Youth alcohol consumption was addressed, emphasizing its prevalence and the need for targeted prevention strategies. Additionally, the use of alcohol in specific populations, such as marginalized or vulnerable groups, was examined, shedding light on unique challenges and patterns of use. Overall, the contributions emphasize the multifaceted nature of alcohol use and the importance of tailored interventions for different demographics.